New IV treatment tested for debilitating spinal arthritis
NCT ID NCT02186873
Summary
This study tested whether an intravenous medication called golimumab could reduce symptoms of active ankylosing spondylitis, a chronic inflammatory disease that causes back pain and stiffness. 208 participants were randomly assigned to receive either the drug or a placebo infusion over 16 weeks. The main goal was to see if the drug helped at least 20% more than placebo in improving pain, function, and inflammation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANKYLOSING SPONDYLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Study site
Glendale, Arizona, United States
-
Study site
Mesa, Arizona, United States
-
Study site
La Palma, California, United States
-
Study site
Granger, Indiana, United States
-
Study site
St Louis, Missouri, United States
-
Study site
Orchard Park, New York, United States
-
Study site
Salisbury, North Carolina, United States
-
Study site
Middleburg Heights, Ohio, United States
-
Study site
Duncansville, Pennsylvania, United States
-
Study site
Austin, Texas, United States
-
Study site
Houston, Texas, United States
-
Study site
Maroochydore, Australia
-
Study site
St. John's, Newfoundland and Labrador, Canada
-
Study site
Burlington, Canada
-
Study site
Trois-Rivières, Canada
-
Study site
Bad Doberan, Germany
-
Study site
Berlin, Germany
-
Study site
Erfurt, Germany
-
Study site
Hamburg, Germany
-
Study site
Planegg, Germany
-
Study site
Ratingen, Germany
-
Study site
Zerbst, Germany
-
Study site
Chihuahua City, Mexico
-
Study site
Bydgoszcz, Poland
-
Study site
Bytom, Poland
-
Study site
Nadarzyn, Poland
-
Study site
Nowa Sól, Poland
-
Study site
Poznan, Poland
-
Study site
Warsaw, Poland
-
Study site
Moscow, Russia
-
Study site
Saint Petersburg, Russia
-
Study site
Saratov, Russia
-
Study site
Smolensk, Russia
-
Study site
Tver', Russia
-
Study site
Ansan, South Korea
-
Study site
Daegu, South Korea
-
Study site
Gwangju, South Korea
-
Study site
Seongdong-Gu, South Korea
-
Study site
Seoul, South Korea
-
Study site
Chernihiv, Ukraine
-
Study site
Dnipropetrovsk, Ukraine
-
Study site
Kyiv, Ukraine
-
Study site
Odesa, Ukraine
-
Study site
Vinnytsia, Ukraine
-
Study site
Zaporizhzhia, Ukraine
Conditions
Explore the condition pages connected to this study.